Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [11] ECONOMIC CONSEQUENCES OF MEDICATION NONADHERENCE IN THE TREATMENT OF SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
    Hong, J.
    Novick, D.
    Haro, J. M.
    Knapp, M.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [12] Tolerability of outpatient antipsychotic treatment:: 36-Month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, D.
    Haro, J. M.
    Suarez, D.
    Bushe, C.
    Lepine, J. P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S161 - S161
  • [13] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [14] Reply to Letter on: Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia 36-Month Results From the European SOHO Study
    Novick, Diego
    Maria Haro, Joseph
    Bertsch, Jordan
    Haddad, Peter M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) : 384 - 385
  • [15] Frequency of response and relapse across different geographical regions: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Novick, D.
    Haro, J. M.
    Brugnoli, R.
    Jordan, B.
    Hong, J.
    Jamie, K.
    Dossenbach, M.
    Alvarez, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 231 - 231
  • [16] Factors associated to risk of relapse in schizophrenia: 24 month results from the schizophrenia outpatients health outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Suarez, D
    Ratcliffe, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S496 - S496
  • [17] Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study
    Novick, Diego
    Maria Haro, Josep
    Suarez, David
    Marques-Teixeira, Joao
    Naber, Dieter
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 203 - 208
  • [18] Use of Mental Health Services and Baseline Factors Associated to Risk of Hospitalisation in Previously Untreated Outpatients with Schizophrenia: 36 Month Results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study
    Novick, D.
    Haro, J. M.
    Bertsch, J.
    Hong, J.
    Montgomery, W.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S32 - S32
  • [19] Factors associated with remission in schizophrenia: 36-months results from the French cohort of the schizophrenia outpatients health outcomes (SOHO) study
    Gasquet, Isabelle
    Avoinet, Sandra
    Chartier, Florence
    Tcherny-Lessenot, Stephanie
    Lepine, Jean-Pierre
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S159 - S160
  • [20] Health-related quality of life (HRQL) and continuous antipsychotic treatment: 36-month results from the SOHO study
    Alonso, J.
    Novick, D.
    Croudace, T.
    Brown, J.
    Gasquet, L.
    Knapp, M.
    Suarez, D.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2007, 10 : S1 - S2